DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Jefferies - 2 Oppenheimer - 2 There's - 1 Eli Lilly - 1 Myers - 1 Andrew Tsai - 1 radiopharma - 1 Jeff Jones - 1
Top related locs:
Biopharma Bristol Mariana radiopharma New Jersey Base Kansas City Immunome
Top related orgs:
Novartis - 1 pharma - 1 Mariana Oncology - 1 Myers Squibb - 1 AstraZeneca - 1 Fusion Pharmaceuticals - 1 RBC Capital Markets - 1 TRT - 1

Search resuls for: "Immunome"


3 mentions found


☆ A corner of the cancer therapy market is heating up—Here are the names investors need to know
  + stars: | 2024-05-23 | by ( Michelle Fox | ) www.cnbc.com   time to read: +8 min
A $25 billion market Meanwhile, RBC Capital Markets sees a $25 billion market opportunity for the space. A name Jones likes is Perspective Therapeutics , which he rates outperform. CATX 1Y mountain Perspective Therapeutics year to date Cantor Fitzgerald is also bullish on the name. So it's really an ideal profile," said Piper Sandler analyst Edward Tenthoff, who doesn't cover Perspective Therapeutics. Then there is Lantheus Holdings , which calls itself a radiopharmaceutical-focused company and has a $5.6 billion market cap.
Persons: There's, Eli Lilly, Myers, Jefferies, Andrew Tsai, radiopharma, Oppenheimer, Jeff Jones, FactSet, William Blair, Read, — it's, Andy Hsieh, Gregory Renza, Jones, Cantor Fitzgerald, Louise Chen, it's, Piper Sandler, Edward Tenthoff, Dan Lyons, Janus Henderson, Lantheus, Roanna Ruiz Organizations: Novartis, pharma, Mariana Oncology, Myers Squibb, AstraZeneca, Fusion Pharmaceuticals, RBC Capital Markets, TRT, Therapeutics, Alpha, Janus, Janus Henderson Investors, Lantheus Holdings, Lantheus, Leerink, ~$ Locations: Biopharma, Bristol, Mariana, radiopharma, New Jersey
☆ Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Apple, Live Nation, Boeing, Coinbase, Amazon & more
  + stars: | 2024-04-30 | by ( Michael Bloom | ) www.cnbc.com   time to read: +5 min
Bank of America reiterates Tesla as buy Bank of America said it's standing by its buy rating on the electric-vehicle maker. "We maintain our Buy rating and raise our PT from $1100 to $1,150." "We are initiating coverage of Live Nation with a Buy rating and $120 price target." "We are initiating coverage on EE with an Overweight rating." "We are initiating coverage of Integral Ad Science with a Buy rating and a $15 price target."
Persons: Tesla, TSLA, Morgan Stanley, Oppenheimer, Raymond James, Mizuho, Airbnb, Coinbase, Needham, Stephens, Jefferies, Ralph Lauren, Chegg Organizations: Argus, Boeing, " Bank of America, Bank of America, UBS, Nvidia, Dyne, JPMorgan, Catalyst Watch, Apple, Mizuho, Citi, BTC, Ethereum, Paramount, CBS, Deutsche Bank, Deutsche, Excelerate Energy, Stephens, Barclays, UMB, Corp, Contineum Locations: Base, Kansas City
☆ Lightning Round: Buy BlackRock 'point blank, period', says Jim Cramer
  + stars: | 2024-01-25 | by ( Jim Cramer | ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Buy BlackRock 'point blank, period', says Jim Cramer'Mad Money' host Jim Cramer weighs in on stock including: Solaredge, Immunome, BlackRock, Hanes and Axsome Therapeutics.
Persons: Jim Cramer Organizations: Hanes, Axsome Therapeutics Locations: Immunome, BlackRock
0 next >>
Total: 3